Clinical trial
Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects
NCT00119587 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00119587 |
|---|---|
| Title | Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects |
| Official title | A Double-Blind, Randomized, Comparative Study of Darbepoetin Alfa Given Once Weekly or Once Every Other Week for Treatment of Anemia in Hemodialysis Subjects |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | darbepoetin alfa |
| Start date | Aug 1, 2002 |
| Completion | Sep 1, 2003 |
| First posted | Jul 14, 2005 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: